Hansol Kim

3 weeks ago | nature.com | Seon Young Kim |Yiyoung Kwon |Eun Sil Kim |Yoon Kim |Hansol Kim |Yon Ho Choe

AbstractA pilot study investigated the cytokine profile (IL-6, TNF-α, IL-17 A, and IL-10) at diagnosis, affecting infliximab (IFX) trough levels (TLs) in pediatric patients with Crohn’s disease (CD). In this follow-up study, we evaluated the changes in cytokine level changes after Crohn’s disease treatment. Cytokines were re-measured after 1 year of treatment. infliximab trough levels and total anti-infliximab antibodies were also measured in patients who had started infliximab treatment.

Nov 25, 2023 | journals.sagepub.com | Chang Dae Lee |Hansol Kim |Rosemarie Cooper |Scott R. Beach

Get full access to this articleView all access and purchase options for this article. Data availability statementThe data are available at here: https://www.nhats.org/. ReferencesAdelman R. D., Tmanova L. L., Delgado D., Dion S., Lachs M. S. (2014). Caregiver burden: A clinical review. JAMA, 311(10), 1052–1060. https://doi.org/10.1001/jama.2014.304Canonici A. P., Andrade L. P., d Gobbi S., Santos-Galduroz R. F., Gobbi L. T. B., Stella F. (2012).